MiMedx Group, Inc. (MDXG) Competitors & Peers
The 5 largest companies in the same industry as MiMedx Group, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $526.19 | P/E 30.2RSI 51Cap 133.4 B |
| REGN | Peer | $788.04 | P/E 19.5RSI 48Cap 81.1 B |
| ARGX | Peer | $959.49 | P/E 36.5RSI 45Cap 60.0 B |
| RVMD | Peer | $204.97 | RSI 41Cap 41.4 B |
| ALNY | Peer | $255.96 | P/E 44.6RSI 56Cap 34.2 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- PINCPartner
Premier acts as a Group Purchasing Organization (GPO) providing its member hospitals and healthcare systems contract access to MiMedx's allograft portfolio.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- GUNZESupplier
Gunze Medical is the exclusive distributor for MiMedx's EpiFix tissue graft products in the Japanese market.
Model-inferred, unverified — treat as a lead, not evidence - ORGOCompetitor
MiMedx competes directly with Organogenesis in the skin substitute and amniotic allograft market (e.g., EpiFix competing with NuShield/Affinity).
Model-inferred, unverified — treat as a lead, not evidence - SNNCompetitor
Smith & Nephew competes with MiMedx in advanced wound care bioengineered scaffolds.
Model-inferred, unverified — treat as a lead, not evidence - IARTCompetitor
Integra competes with MiMedx Group in surgical reconstruction and advanced wound dressing markets.
Model-inferred, unverified — treat as a lead, not evidence - VACustomer
The US Department of Veterans Affairs (VA) hospitals and clinics represent a major customer group for MiMedx wound care products.
Model-inferred, unverified — treat as a lead, not evidence - VIZIENTPartner
Vizient is a major GPO partner that lists MiMedx skin substitute products on its contracts for member hospitals.
Model-inferred, unverified — treat as a lead, not evidence - VCELCompetitor
Vericel and MiMedx compete in the cellular therapy and advanced wound care sectors.
Model-inferred, unverified — treat as a lead, not evidence